Concepedia

Author

Corina Herscovici

Tel Aviv University

Also Known As

C Herscovici, C. Herscovici, Corina Herscovici

13

Publications

275

Citations

6

H-Index

20

Concepts

All Affiliations

Tel Aviv UniversityRabin Medical Center
CH

About

Corina Herscovici is an author at Tel Aviv University specializing in blood transplantation, medicine, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

244

2

Blood Transplantation

5

5

244

3

Health Sciences

2

2

43

4

Cellular Therapies

1

1

79

5

Classical Hematology

1

1

20

Corina Herscovici

×

6

Publications

259

Citations

6

H-Index

YearCitations

Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan

Avichai Shimoni, Izhar Hardan, Noga Shem‐Tov,

Leukemia

2007

106

Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study

Moshe Yeshurun, Ofer Shpilberg, Corina Herscovici,

Biology of Blood and Marrow Transplantation

2015

79

Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study

Moshe Yeshurun, Iuliana Vaxman, Liat Shargian,

Clinical Microbiology and Infection

2017

23

Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato‐oncological patients: Randomized controlled trial

Mical Paul, Ron Ram, Eitan Kugler,

American Journal of Hematology

2013

20

Elevation of CRP precedes clinical suspicion of bloodstream infections in patients undergoing hematopoietic cell transplantation

Ron Ram, Moshe Yeshurun, L. Farbman,

Journal of Infection

2013

16

High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia-is more better or more of the same?

Ofir Wolach, Gilad Itchaki, Michal Bar‐Natan,

Hematological Oncology

2015

15

Page 1